Skip to main content

The Association Between N-Methylglucamine Antimoniate and Pancreatitis in Dogs with Leishmaniasis

  • Chapter
  • First Online:
Veterinary Science

Abstract

In this study, the possible association between pancreatitis and treatment with methylglucamine antimoniate (MA) in dogs with leishmaniasis was evaluated. Of the 20 dogs included, three dogs showed clinical signs of pancreatitis. Abdominal ultrasound abnormalities suggestive of pancreatitis were observed in two dogs, and increased cPLI was observed in four cases. The statistical results showed a low probability of development of pancreatitis in patients treated with MA. However, considering the possible recurrence of pancreatitis in four cases in our study, we suggest that dogs treated with MA should be evaluated for pancreatitis, especially when compatible clinical signs are present.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

CanL:

Canine leishmaniasis

cPLI:

Canine pancreatic lipase immunoreactivity

MA:

Meglumine antimoniate

UP/UC:

Urinary protein/urinary creatinine ratio

References

  • Aste G, Di Tommaso M, Steiner JM, Williams DA, Boari A (2005) Pancreatitis associated with N-methyl-glucamine therapy in a dog with leishmaniasis. Vet Res Commun 29(suppl 2):269–272

    Google Scholar 

  • Barthet M, Brunet P, Bernard JC, Dussol B, Rodor F, Jouglard J, Berland Y (1994) Acute pancreatitis during treatment with meglumine antimoniate (Glucantime). Gastroenterol Clin Biol 18(1):90–92

    PubMed  CAS  Google Scholar 

  • De Lalla F, Pellizzer G, Gradoni L, Vespignani M, Franzetti M, Stecca C (1993) Acute pancreatitis associated with the administration of meglumine antimoniate for the treatment of visceral leishmaniasis. Clin Infect Dis 16(5):730–731

    Article  PubMed  Google Scholar 

  • Kuyucu N, Kara C, Bakirtaç A, Teziç T (2001) Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in a infant who developed pancreatitis caused by meglumine antimoniate. Pediatr Infect Dis J 20(4):455–457

    Article  PubMed  CAS  Google Scholar 

  • Lambertucci JR, Franca BM, De Melo QE (2004) Acute pancreatitis caused by meglumine antimoniate given for the treatment of visceral leishmaniasis. Rev Soc Bras Med Trop 37(1):74–75

    Article  PubMed  Google Scholar 

  • Liorente S, Gimeno L, Navarro MJ, Moreno S, Rodriguez-Gironés M (2000) Therapy of visceral Leishmaniasis in renal transplant recipients intolerant to pentavalent antimonials. Transplant 70(5):800–801

    Article  Google Scholar 

  • McCord K, Davis J, Leyva F, Armstrong PJ, Simpson KW, Rishniw M, Forman MA, Biller DS (2007) A multi-institutional study evaluating diagnostic utility of Spec cPLâ„¢ in the diagnosis of acute pancreatitis in dogs. In: Proceedings of 27th ACVIM, Montréal, Quebec 47

    Google Scholar 

  • Mirò G, Cardoso L, Pennisi MG, Oliva G, Baneth G (2008) Canine leishmaniasis – new concepts and insights on an expanding zoonosis: part two. Trends Parasitol 24(8):371–377

    Article  PubMed  Google Scholar 

  • Newman S, Steiner J, Woosley K, Barton L, Ruaux C, Williams D (2004) Localization of pancreatic inflammation and necrosis in dogs. J Vet Intern Med 18:488–493

    Article  PubMed  Google Scholar 

  • Paltrinieri S, Solano-Gallego L, Fondati A, Lubas G, Gradoni L, Castagnaro M, Crotti A, Maroli M, Oliva G, Roura X, Zatelli A, Zini E (2010) Guidelines for diagnosis and clinical classification of leishmaniasis in dogs. J Am Vet Med Assoc 236(11):1184–1191

    Article  PubMed  Google Scholar 

  • Shahian M, Alborzi A (2009) Effect of meglumine antimoniate on the pancreas during treatment of visceral leishmaniasis in children. Med Sci Monit 15(6):290–293

    Google Scholar 

  • Steiner JM (2003) Diagnosis of pancreatitis. Vet Clin North Am Small Anim Pract 33:1181–1195

    Article  PubMed  Google Scholar 

  • Steiner JM, Newman SJ, Xenoulis PG, Woosley K, Suchodolski JS, Williams DA, Barton L (2008) Sensitivity of serum markers for pancreatitis in dogs with macroscopic evidence of pancreatitis. Vet Ther 9(4):263–273

    PubMed  Google Scholar 

  • Valladares JE, Riera C, Alberola J, Gállego M, Portús M, Cristòfol C, Franquelo C, Arboix M (1998) Pharmacokinetics of meglumine antimoniate after administration of a multiple dose in dogs experimentally infected with Leishmania infantum. Vet Parasitol 75:33–40

    Article  PubMed  CAS  Google Scholar 

  • Xenoulis PG, Saridomichelakis MN, Chatzis MK, Suchodolski JS, Steiner JM (2010) Serum Spec cPLs Concentrations in Leishmania infantum-Infected Dogs Treated With Meglumine Antimonate. J Vet Intern Med 24:752

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Boari .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Boari, A. et al. (2012). The Association Between N-Methylglucamine Antimoniate and Pancreatitis in Dogs with Leishmaniasis. In: Pugliese, A., Gaiti, A., Boiti, C. (eds) Veterinary Science. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-23271-8_11

Download citation

Publish with us

Policies and ethics